Latest News

View allAccessAL amyloidosisCAR-TConferencesMPEMyelomaNewsPatient evidenceSin categoríaVideos

Myeloma Patients Europe (MPE) holds first Myeloma CAB

  In addition to providing education, information and support to its 46 member-groups across 30 European countries, Myeloma Patients Europe (MPE) advocates for the best possible research and equal access to the most innovative treatment and care. With this aim, MPE has developed a series of Community Advisory Boards (CABs) focused on myeloma.

Read more

In Memoriam of Peter Lens

  It is with great sadness that we share that our friend and colleague, Peter Lens, has passed away. Peter was a myeloma patient and member of the first Board of Myeloma Patients Europe (MPE). He was always very passionate and supportive of MPE, its Board and staff.

Read more

Results of MPE members participation in EMA survey on bortezomib

As bortezomib, an anti-myeloma medicine, is licensed as both an intravenous (IV – through the vein via a drip) and subcutaneous medicine (through the skin, via an injection), the European Medicines Agency (EMA) recently conducted a survey to understand which method was most commonly used across Europe. They also asked about the location of administration…

Read more

Myeloma Patients Europe webinar on CAR-T cell treatment

Patient advocates, patients and caregivers have heard a lot about CAR-T cell treatment and its potential in myeloma. However, there are still a lot of questions about its benefits, its challenges and its role in treating myeloma. With the aim of providing an overview of CAR-T cell treatment in myeloma, healthcare professional expectations and an…

Read more

Open call to participate in the Advocate Development Programme (ADP)

Patient input into medical research is becoming increasingly important. The MPE Advocate Development Programme aims to help myeloma and AL amyloidosis advocates understand the research and development process of drugs, from the preclinical stages through to post-marketing surveillance and national access. Topics include clinical trial design, regulation, pricing and health technology assessment (HTA). The programme…

Read more
June

July 2026

August
MO
TU
WE
TH
FR
SA
SU
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
Events for 1st July
No Events
Events for 2nd July
No Events
Events for 3rd July
No Events
Events for 4th July
No Events
Events for 5th July
No Events
Events for 6th July
No Events
Events for 7th July
No Events
Events for 8th July
No Events
Events for 9th July
No Events
Events for 10th July
No Events
Events for 11th July
No Events
Events for 12th July
No Events
Events for 13th July
No Events
Events for 14th July
No Events
Events for 15th July
No Events
Events for 16th July
No Events
Events for 17th July
No Events
Events for 18th July
No Events
Events for 19th July
No Events
Events for 20th July
No Events
Events for 21st July
No Events
Events for 22nd July
No Events
Events for 23rd July
No Events
Events for 24th July
No Events
Events for 25th July
No Events
Events for 26th July
No Events
Events for 27th July
No Events
Events for 28th July
No Events
Events for 29th July
No Events
Events for 30th July
No Events
Events for 31st July
No Events